About Us

About XYone Therapeutics

XYone Therapeutics is a biotech startup seeking to develop drugs & diagnostic solutions for significant unmet medical needs in the fields of endocrine dysregulation & immuno-oncology.

Anshu Goyal

Cofounder, CEO

Dr. Ravi Jasuja

Cofounder, Chief Scientific Officer

Dr Surender Kharbanda

Chief Operating Office

Dr Shalender Bhasin

Cofounder, Head Scientific Advisory Board

Govind Panchamoorthy

VP, Immuno Oncology

Brian Lawney, Ph.D.

Director of Computational Science

Dylan Bulesco

Chief Commercialization Officer

Sam Mawn Mahlau

Corporate Counsel

Dr. Adrian Dobs

MD, Director Johns Hopkins Clinical Research Network, Prof Johns Hopkins School of Medicine

Dr. Ronald Swerdloff

Chief, Div of Endocrinology, Prof of Medicine, David Geffen School of Medicine at UCLA

Dr. Neeraj Agarwal

Professor & Presidential Endowed Chair of Cancer Research at Huntsman Cancer Institute, Univ of Utah.

Dr Ravi Chari

Chief Scientific Officer at Full Life Technologies, Vice President Chemistry & Biochemistry at ImmunoGen Inc, Fellow AIMBE

Dr Rakesh Dixit

President & CEO Bionavigen, Vice President MedImmune R&D Global head of Biologics Safety, Vice President R&D , Biologics Safety AstraZeneca

Dr David Weaver

ex Chief Scientific Officer at FemtoDx and DNAR, Vice President at Verastem Oncology and ex-faculty CBR Institute for Biomedical research, Harvard Medical School and Dana Farber Cancer Institute

Dr. Anne Cappola

MD, ScM, Professor, Hospital of the University of Pennsylvania, Philadelphia

Dr. Manu Jaggi

COO at Dabur Research Foundation & Althea Lifesciences.

Anshu Goyal

Cofounder, CEO

Dr Ravi Jasuja

Cofounder, Chief Scientific Officer

Ashu Garg